此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Exploring the Interplay Between Maternal Stress, Human Milk, and Epigenetic Changes in Preterm Infant's Neurodevelopment (EMBRACE)

2026年11月11日 更新者:Camilla Fontana、Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Preterm birth represents a major challenge in pediatric healthcare, as preterm infants are at increased risk of neonatal complications and long-term neurodevelopmental impairments. Several factors may contribute to these outcomes, including gestational age at birth, postnatal comorbidities, and the neonatal intensive care unit (NICU) environment. Furthermore, preterm birth and prolonged hospitalization may negatively affect maternal psychological well-being, increasing the risk of stress, anxiety, and depression. These conditions may influence maternal sensitivity and responsiveness, mother-infant interactions, and infant neurodevelopment.

Emerging evidence suggests that maternal mental health may affect infant neurodevelopment through both direct biological mechanisms, such as epigenetic regulation, and indirect pathways, including changes in breast milk composition. Cortisol, a stress-related hormone present in breast milk and saliva, may play a role in stress regulation and neurobehavioral development. In particular, the methylation of Long Interspersed Nuclear Element-1 (LINE-1 or L1), a mobile genetic element involved in genomic regulation, may be influenced by environmental factors and early maternal care. Preliminary findings indicate that preterm infants exhibit lower L1 promoter methylation levels at birth than term infants, while early maternal care may modulate these levels and support neurobehavioral development.

The EMBRACE study aims primarily to investigate the relationship between biological maternal stress, measured through salivary cortisol levels, and L1 promoter methylation in blood samples collected from preterm infants from birth to 12 months of corrected age. Secondary objectives include examining this relationship in buccal swab samples, assessing associations between maternal perceived stress, anxiety, and depression and infant L1 methylation, and investigating the relationship between maternal psychological and biological stress indicators and infant neurodevelopmental outcomes. The study will also explore associations between perceived maternal stress and cortisol concentrations in breast milk and saliva, as well as longitudinal changes in L1 methylation.

This is a non-pharmacological, observational cohort study conducted at the Neonatology and Neonatal Intensive Care Unit of the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan, Italy. Participants will include preterm infants born between 24+0 and 30+6 weeks of gestational age and their mothers. Assessments will be conducted at five time points: birth, transition to intermediate care or 34 weeks of postmenstrual age, hospital discharge, 6 months, and 12 months of corrected age. Maternal assessments will include standardized questionnaires evaluating stress, anxiety, and depression, as well as cortisol measurements in saliva and breast milk. Infant assessments will include L1 methylation analyses in blood and buccal samples and standardized neurodevelopmental evaluations as part of routine clinical follow-up. No additional invasive procedures will be performed, as blood samples will be collected during routine clinical care.

The study is expected to improve understanding of the relationships between maternal stress, anxiety, depression, epigenetic regulation, and neurodevelopment in preterm infants. It will also investigate the potential role of breast milk cortisol in these associations. Ultimately, the findings may contribute to the development of early interventions aimed at improving neurodevelopmental outcomes in preterm infants and supporting maternal psychological well-being.

研究概览

研究类型

观察性的

注册 (估计的)

96

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Lombardy
      • Milan、Lombardy、意大利、20122
        • 招聘中
        • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
        • 接触:
        • 副研究员:
          • Chiara Bonfanti
        • 副研究员:
          • Agnese De Carli
        • 副研究员:
          • Monica Fumagalli
        • 副研究员:
          • Mary Giorgia Gaccione

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

5个月 至 6个月 (孩子)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

All preterm infants born at the SC Neonatologia e Terapia Intensiva Neonatale - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano and their mothers.

描述

Inclusion Criteria:

  • Preterm infants born between 24+0 and 30+6 weeks of gestational age (GA);
  • Mothers aged ≥ 18 years with adequate understanding of the Italian language;
  • Signed informed consent from parents.

Exclusion Criteria:

  • Parents decline participation;
  • Infants with major congenital anomalies, malformations, or genetic syndromes;
  • Mothers with obvious psychiatric conditions, cognitive deficits, or active substance abuse at the time of delivery.
  • Infants birth samples not available (both buccal swab and blood)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Epigenetic changes on LINE1 (blood samples)
大体时间:up to 48 weeks post menstrual age

epigenetic analysis is performed on cord blood samples collected at birth, at transition to intermediate care and at hospital discharge on peripheral blood samples

up to 48 weeks post menstrual age
Maternal salivary cortisol
大体时间:up to 12 months corrected age of the infant

Collected at birth, transition to intermediate care, discharge

up to 12 months corrected age of the infant

次要结果测量

结果测量
措施说明
大体时间
Human milk cortisol concentrations
大体时间:up to 6 months corrected age of the infant

Collected at birth, transition to intermediate care, discharge

up to 6 months corrected age of the infant
Buccal swab
大体时间:up to 12 months corrected age

Collected at birth, 34 weeks GA, discharge, 6 and 12 months corrected age

up to 12 months corrected age
Neurological outcome
大体时间:up to 44 weeks post menstrual age

Hammersmith neonatal neurological examination performed at NICU discharge

up to 44 weeks post menstrual age
Neonatal Visual Assessment
大体时间:up to 44 weeks post menstrual age

Neonatal visual function in assessed at discharge using the Visual Assessment battery developed by Ricci et al. The assessment has 9 items and each one is scored as normal or abnormal according to the description given by the authors.

up to 44 weeks post menstrual age
Neonatal behavior
大体时间:up to 44 weeks post menstrual age

Neonatal behavior is assessed using the Neonatal Behavior Assessment Scale, and in particular the areas of state organization, state regulation, and the autonomic system. Each item will be scored according to the description given by the author of the assessment

up to 44 weeks post menstrual age
Neurodevelopmental outcome
大体时间:from 6 to 12 months corrected age

Bayley scales to assess neurodevelopment at 6 and 12 months corrected age. The normal range for the composite score is 100 +/- 15 points. Higher scores mean better outcomes.

from 6 to 12 months corrected age
Maternal depression
大体时间:up to 12 months corrected age of the infant

Assessed with the Edinburgh Postnatal depression scale. Responses are scored 0 to 3. A score above 8 is considered pathological in the post partum period. It will be administered at birth, at transition to intermediate care, at NICu discharge at 6 and 12 months corrected age.

up to 12 months corrected age of the infant
Maternal stress in the NICU
大体时间:up to 12 months corrected age of the infant

Assessed with the Parental Stressor Scale: Neonatal Intensive Care Unit (PSS:NICU). It is composed of 35 items that are scored on a 5-point Likert scale ranging from 1 (not stressful at all) to 5 (extremely stressfull). It will be administered at birth, at transition to intermediate care and at NICu discharge.

up to 12 months corrected age of the infant
Maternal bonding
大体时间:up to 12 months corrected age of the infant

Assessed with the Postpartum Bonding Questionnaire (PBQ) administered at NICU discharge, 6 and 12 months corrected age. A score above 26 is considered pathological.

up to 12 months corrected age of the infant
Maternal anxiety and depression
大体时间:up to 12 months corrected age of the infant

Assessed with the hospital anxiety and depression scale (HAD-S). It will be administered at birth, at transition to intermediate care, at NICu discharge at 6 and 12 months corrected age. A score from 0 to 7 is normal, 8-10 borderline and 11-21 score in the clinical range.

up to 12 months corrected age of the infant
Parenting stress
大体时间:up to 12 months corrected age of the infant

Assessed with the Parenting Stress Index Scale. Administered at 6 and 12 months corrected age. It is composed of 36 items that are scored on a 5-point Likert scale ranging from 1 (not stressful at all) to 5 (extremely stressful)

up to 12 months corrected age of the infant

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年8月25日

初级完成 (估计的)

2027年6月1日

研究完成 (估计的)

2028年12月1日

研究注册日期

首次提交

2026年11月5日

首先提交符合 QC 标准的

2026年11月11日

首次发布 (实际的)

2026年11月17日

研究记录更新

最后更新发布 (实际的)

2026年11月17日

上次提交的符合 QC 标准的更新

2026年11月11日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • EMBRACE

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅